AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-6.54%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.36B
AUM Growth
+$1.36B
(+9%)
Cap. Flow
+$305M
Cap. Flow
% of AUM
22.39%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
106
New
37
Increased
27
Reduced
9
Closed
29
Top Buys
| 1 |
Burlington
BURL
|
$40.9M |
| 2 |
Amazon
AMZN
|
$37M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$32.3M |
| 4 |
Energizer
ENR
|
$26.4M |
| 5 |
Dollar General
DG
|
$25M |
Top Sells
| 1 |
Williams-Sonoma
WSM
|
$32.8M |
| 2 |
AutoZone
AZO
|
$29.4M |
| 3 |
Envista
NVST
|
$25.1M |
| 4 |
Biogen
BIIB
|
$22.1M |
| 5 |
Estee Lauder
EL
|
$20.7M |
Sector Composition
| 1 | Healthcare | 55.8% |
| 2 | Consumer Staples | 16.35% |
| 3 | Consumer Discretionary | 16.01% |
| 4 | Technology | 4.95% |
| 5 | Industrials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $69.8M | 4.32% | 28,160,605 +7,477,372 | +36% | +$18.5M |
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $54M | 3.34% | 3,000,000 +1,288,000 | +75% | +$23.2M |
|
3
Vanda Pharmaceuticals
VNDA
$279M
| $47.3M | 2.93% | 4,568,000 +1,740,000 | +62% | +$18M |
|
|
4
Amazon
AMZN
$2.44T
| $44.8M | 2.77% | 23,000 +19,000 | +475% | +$37M |
|
|
VXRT
5
DELISTED
Vaxart
VXRT
| $44.6M | 2.76% | 25,200,000 | – | – |
|
|
6
Burlington
BURL
$18.3B
| $40.9M | 2.53% | +258,004 | New | +$40.9M |
|
7
Incyte
INCY
$16.5B
| $38.7M | 2.39% | 528,000 +253,000 | +92% | +$18.5M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $38.4M | 2.38% | 428,000 +360,000 | +529% | +$32.3M |
|
9
Central Garden & Pet Class A
CENTA
$2.08B
| $38.4M | 2.37% | 1,500,000 +622,000 | +71% | +$15.9M |
|
10
Bristol-Myers Squibb
BMY
$96B
| $36.1M | 2.23% | 648,000 +148,000 | +30% | +$8.25M |
|
|
BHVN
11
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $35.9M | 2.22% | 1,056,000 +444,000 | +73% | +$15.1M |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $31.3M | 1.93% | 64,000 -36,000 | -36% | -$17.6M |
|
13
Dropbox
DBX
$7.84B
| $30.6M | 1.89% | 1,692,000 +234,000 | +16% | +$4.24M |
|
14
Deckers Outdoor
DECK
$17.7B
| $30.5M | 1.89% | 227,518 +43,418 | +24% | +$5.82M |
|
|
BLUE
15
DELISTED
bluebird bio
BLUE
| $29.8M | 1.84% | 648,000 +312,000 | +93% | +$14.3M |
|
16
Kraft Heinz
KHC
$33.1B
| $29.7M | 1.84% | 1,200,000 +510,000 | +74% | +$12.6M |
|
17
Enanta Pharmaceuticals
ENTA
$180M
| $29.2M | 1.81% | 568,000 +174,105 | +44% | +$8.95M |
|
18
PTC Therapeutics
PTCT
$3.92B
| $26.8M | 1.66% | 600,000 -158,000 | -21% | -$7.05M |
|
|
19
Energizer
ENR
$1.88B
| $26.4M | 1.63% | +872,000 | New | +$26.4M |
|
|
AMAG
20
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $25.5M | 1.57% | 4,120,000 +60,000 | +1% | +$371K |
|
|
21
Dollar General
DG
$23.9B
| $25M | 1.55% | +165,633 | New | +$25M |
|
|
MRTX
22
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $24M | 1.48% | 312,000 +192,000 | +160% | +$14.8M |
|
23
Five Below
FIVE
$8B
| $23.5M | 1.46% | 334,594 +244,137 | +270% | +$17.2M |
|
24
Merck
MRK
$210B
| $23.1M | 1.43% | 300,000 +220,000 | +275% | +$16.9M |
|
25
CVS Health
CVS
$92.8B
| $22.4M | 1.39% | +378,000 | New | +$22.4M |
|